Skip to content
healthcare.dev

EKTERLY

NDC 82928-300, sebetralstat, tablet, from KalVista Pharmaceuticals Ltd.

Product NDC
82928-300
Status
Listed
Labeler
KalVista Pharmaceuticals Ltd
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA219301
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/82928-300 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SEBETRALSTAT300 mg/1

Pharmacologic classes

Kallikrein Inhibitors [MoA]; Plasma Kallikrein Inhibitor [EPC]

Package NDCNDC-11Package
82928-300-04829280300044 BLISTER PACK in 1 CARTON (82928-300-04) / 1 TABLET in 1 BLISTER PACK (82928-300-01)
82928-300-05829280300052 BLISTER PACK in 1 CARTON (82928-300-05) / 2 TABLET in 1 BLISTER PACK (82928-300-02)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1d145e2f-8e7e-2e90-e063-6294a90a4449

Use it

Look up 82928-300 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/82928-300 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 82928-300. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.